Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $746.23 | 18 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $421.04 | 5 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $123.91 | 4 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $87.95 | 4 | $0 (2020) |
| Edwards Lifesciences Corporation | $64.33 | 2 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $34.60 | 2 | $0 (2024) |
| ATRICURE, INC. | $14.40 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $245.72 | 5 | Abbott Laboratories ($172.44) |
| 2023 | $155.90 | 3 | Abbott Laboratories ($137.74) |
| 2022 | $110.86 | 1 | Abbott Laboratories ($110.86) |
| 2020 | $43.51 | 2 | Edwards Lifesciences Corporation ($21.89) |
| 2019 | $25.21 | 1 | Novartis Pharmaceuticals Corporation ($25.21) |
| 2018 | $110.00 | 3 | Merck Sharp & Dohme Corporation ($110.00) |
| 2017 | $55.03 | 3 | Novartis Pharmaceuticals Corporation ($41.12) |
All Payment Transactions
18 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/15/2024 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $42.44 | General |
| 07/08/2024 | ATRICURE, INC. | EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/06/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $141.75 | General |
| Category: Heart Failure | ||||||
| 03/06/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $16.44 | General |
| Category: Cardiovascular | ||||||
| 01/17/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $30.69 | General |
| Category: Heart Failure | ||||||
| 12/12/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $18.16 | General |
| Category: Cardiovascular | ||||||
| 10/03/2023 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $3.48 | General |
| Category: Heart Failure | ||||||
| 05/03/2023 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $134.26 | General |
| Category: Heart Failure | ||||||
| 03/21/2022 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $110.86 | General |
| Category: Heart Failure | ||||||
| 03/09/2020 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $21.89 | General |
| 02/19/2020 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/14/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $25.21 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/04/2018 | Merck Sharp & Dohme Corporation | MK-1242 (Drug) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/04/2018 | Merck Sharp & Dohme Corporation | MK-1242 (Drug) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/04/2018 | Merck Sharp & Dohme Corporation | MK-1242 (Drug) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/12/2017 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $13.91 | General |
| 10/11/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/25/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $27.49 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 33 | 3,480 | 4,416 | $704,571 | $237,906 |
| 2022 | 33 | 3,590 | 4,700 | $709,022 | $237,356 |
| 2021 | 35 | 3,450 | 4,617 | $660,863 | $238,797 |
| 2020 | 36 | 3,091 | 3,742 | $596,135 | $203,367 |
All Medicare Procedures & Services
181 procedure records from CMS Medicare Utilization — Page 3 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 104 | 104 | $35,152 | $13,163 | 37.4% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 74 | 74 | $38,505 | $12,247 | 31.8% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2022 | 48 | 238 | $21,856 | $6,727 | 30.8% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2022 | 651 | 930 | $25,110 | $6,417 | 25.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 67 | 113 | $21,470 | $6,312 | 29.4% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2022 | 67 | 67 | $15,636 | $4,947 | 31.6% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2022 | 26 | 104 | $11,840 | $4,849 | 41.0% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Office | 2022 | 48 | 238 | $14,042 | $4,521 | 32.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 54 | 63 | $15,332 | $3,946 | 25.7% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2022 | 47 | 47 | $11,689 | $3,841 | 32.9% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2022 | 66 | 66 | $15,312 | $3,541 | 23.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 23 | 23 | $9,246 | $3,444 | 37.2% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Facility | 2022 | 98 | 98 | $8,820 | $2,715 | 30.8% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2022 | 26 | 28 | $11,424 | $2,313 | 20.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 23 | 28 | $7,112 | $2,294 | 32.2% |
| 93264 | Remote monitoring of pulmonary artery pressure sensor, up to 30 days | Office | 2022 | 12 | 53 | $5,353 | $2,128 | 39.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 15 | 19 | $6,215 | $2,023 | 32.5% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2022 | 30 | 52 | $8,460 | $1,873 | 22.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 16 | 16 | $5,408 | $1,444 | 26.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 13 | 13 | $3,523 | $1,391 | 39.5% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Office | 2022 | 82 | 82 | $4,100 | $1,344 | 32.8% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2022 | 66 | 68 | $4,488 | $1,317 | 29.3% |
| 93350 | Ultrasound of heart during rest, exercise and/or drug-induced stress with report | Facility | 2022 | 23 | 23 | $3,998 | $1,204 | 30.1% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2022 | 16 | 16 | $3,418 | $1,179 | 34.5% |
| 93350 | Ultrasound of heart during rest, exercise and/or drug-induced stress with report | Office | 2022 | 15 | 15 | $3,354 | $1,080 | 32.2% |
About Dr. Lance Richards, DO
Dr. Lance Richards, DO is a Internal Medicine healthcare provider based in Fort Collins, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/03/2008. The National Provider Identifier (NPI) number assigned to this provider is 1396908901.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lance Richards, DO has received a total of $746.23 in payments from pharmaceutical and medical device companies, with $245.72 received in 2024. These payments were reported across 18 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($746.23).
As a Medicare-enrolled provider, Richards has provided services to 13,611 Medicare beneficiaries, totaling 17,475 services with total Medicare billing of $917,425. Data is available for 4 years (2020–2023), covering 181 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Cardiovascular Disease, Internal Medicine
- Location Fort Collins, CO
- Active Since 07/03/2008
- Last Updated 12/26/2014
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1396908901
Products in Payments
- CARDIOMEMS (Device) $421.04
- MK-1242 (Drug) $110.00
- ENTRESTO (Drug) $87.95
- ELIQUIS (Drug) $18.16
- CAMZYOS (Drug) $16.44
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) $14.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Fort Collins
Steven Schuster, M.d, M.D
Internal Medicine — Payments: $347,736
Dr. Justin Strote, M.d, M.D
Internal Medicine — Payments: $65,289
Jason Mayer, M.d, M.D
Internal Medicine — Payments: $41,797
Russell Heath, Md, MD
Internal Medicine — Payments: $9,459
Allison Schneider, D.o, D.O
Internal Medicine — Payments: $6,736
Dr. Alejandro Munoz, M.d, M.D
Internal Medicine — Payments: $6,564